Loading...
♣ Downloaded data
♣ Processed data according to the description of the paper
| Methods/Resource | Reagent | Species | Cell line / Condition | Number of bases with score | Data Type |
| PARS (Nature, 2010) | V1 & S1 | Yeast | S288C in_vivo | 3,254,906 | transcriptome-wide |
| PARS (Nature, 2014) | V1 & S1 | Human | GM12878 native deproteinized in_vitro | 240,200 | transcriptome-wide |
| GM12878 native deproteinized followed by renatured in_vitro | 40,879 | transcriptome-wide | |||
| GM12878 renatured in_vitro | 3,265,933 | transcriptome-wide | |||
| GM12891 renatured in_vitro | 2,526,825 | transcriptome-wide | |||
| GM12892 renatured in_vitro | 2,921,326 | transcriptome-wide | |||
| PARTE (Mol Cell, 2012) | V1 | Yeast | S288C 23℃ in_vitro | 1,029,095 | transcriptome-wide |
| S288C 30℃ in_vitro | 953,300 | transcriptome-wide | |||
| S288C 37℃ in_vitro | 983,672 | transcriptome-wide | |||
| S288C 55℃ in_vitro | 1,084,136 | transcriptome-wide | |||
| S288C 75℃ in_vitro | 765,720 | transcriptome-wide | |||
| DMS-seq (Nature, 2014) | DMS | Human | K562 in_vivo | 7,095,073 | transcriptome-wide |
| K652 in_vitro | 2,722,195 | transcriptome-wide | |||
| K562 denatured | 4,391,436 | transcriptome-wide | |||
| FBL in_vivo | 1,336,825 | transcriptome-wide | |||
| FBL in_vitro | 2,872,416 | transcriptome-wide | |||
| FBL denatured | 1,435,069 | transcriptome-wide | |||
| DMS | Yeast | BY4741 in_vivo | 2,120,926 | transcriptome-wide | |
| BY4741 in_vitro | 1,501,023 | transcriptome-wide | |||
| BY4741 denatuerd | 1,472,051 | transcriptome-wide | |||
| DMS-seq & SHAPE (Science, 2016) | None | Human | HEK293T K+ no-reagent | 509,106 | transcriptome-wide |
| HEK293T Na+ no-reagent | 384,681 | transcriptome-wide | |||
| HeLa K+ no-reagent | 455,380 | transcriptome-wide | |||
| HeLa Na+ no-reagent | 713,806 | transcriptome-wide | |||
| DMS | Mouse | mES DMS in_vitro 95℃ | 234,705 | transcriptome-wide | |
| mES DMS in_vitro 0mM K+ | 1,454,858 | transcriptome-wide | |||
| mES DMS in_vitro 150mM K+ | 384,510 | transcriptome-wide | |||
| mES DMS in_vivo PDS | 1,426,567 | transcriptome-wide | |||
| mES DMS in_vivo | 1,596,053 | transcriptome-wide | |||
| NAI | mES NAI in_vitro 0mM K+ | 2,681,830 | transcriptome-wide | ||
| mES NAI in_vitro 150mM K+ | 3,076,217 | transcriptome-wide | |||
| mES NAI in_vivo | 5,171,130 | transcriptome-wide | |||
| None | mES K+ no-reagent | 309,922 | transcriptome-wide | ||
| mES Na+ no-reagent | 86,082 | transcriptome-wide | |||
| mES Li+ no-reagent | 135,738 | transcriptome-wide | |||
| DMS | Yeast | yRH101 DMS in_vitro 0mMK+ | 2,611,745 | transcriptome-wide | |
| yRH101 DMS in_vitro 150mMK+ | 2,202,509 | transcriptome-wide | |||
| yRH101 DMS in_vivo | 2,326,412 | transcriptome-wide | |||
| None | yRH101 K+ no-reagent | 1,333,943 | transcriptome-wide | ||
| yRH101 Na+ no-reagent | 1,645,607 | transcriptome-wide | |||
| DMS | E.coli | TOP10 DMS in_vitro 0mMK+ | 71,848 | transcriptome-wide | |
| TOP10 DMS in_vitro 150mMK+ | 57,462 | transcriptome-wide | |||
| TOP10 DMS in_vivo | 42,686 | transcriptome-wide | |||
| None | TOP10 K+ no-reagent | 42,095 | transcriptome-wide | ||
| TOP10 Na+ no-reagent | 39,846 | transcriptome-wide | |||
| DMS | P.putida | KT2440 DMS in_vitro 0mMK+ | 354,429 | transcriptome-wide | |
| KT2440 DMS in_vitro 150mMK+ | 286,808 | transcriptome-wide | |||
| KT2440 DMS in_vivo | 317,943 | transcriptome-wide | |||
| None | KT2440 K+ no-reagent | 27,906 | transcriptome-wide | ||
| KT2440 Na+ no-reagent | 26,050 | transcriptome-wide | |||
| DMS | Synechococcus | WH8102 DMS in_vitro 0mMK+ | 9,752 | transcriptome-wide | |
| WH8102 DMS in_vitro 150mMK+ | 10,176 | transcriptome-wide | |||
| None | WH8102 K+ no-reagent | 5,455 | transcriptome-wide | ||
| WH8102 Na+ no-reagent | 5,239 | transcriptome-wide | |||
| DMS-seq (NSMB, 2018) | DMS | Zebrafish | GRCZ11 DMS in_vivo 64c | 5,027,519 | transcriptome-wide |
| GRCZ11 DMS in_vivo sphere | 3,621,907 | transcriptome-wide | |||
| GRCZ11 DMS in_vivo shield | 3,538,202 | transcriptome-wide | |||
| GRCZ11 DMS in_vitro | 5,209,188 | transcriptome-wide | |||
| GRCZ11 DMS in_vivo 64c for translation inhibition | 3,551,200 | transcriptome-wide | |||
| GRCZ11 DMS in_vivo 64c PatA treated for translation inhibition | 4,398,966 | transcriptome-wide | |||
| GRCZ11 DMS in_vivo 64c CHX treated for translation inhibition | 3,253,266 | transcriptome-wide | |||
| DMS-seq (eLife, 2017) | DMS | E.coli | MG1655 37℃ in_vitro WT | 90,566 | transcriptome-wide |
| MG1655 95℃ in_vitro WT | 247,648 | transcriptome-wide | |||
| MG1655 37℃ in_vivo WT | 1,058,069 | transcriptome-wide | |||
| MG1655 37℃ in_vivo dusB-M3 | 698,581 | transcriptome-wide | |||
| MG1655 37℃ in_vivo dusB-M3:2 | 561,410 | transcriptome-wide | |||
| MG1655 37℃ in_vivo ∆gcvB | 679,085 | transcriptome-wide | |||
| MG1655 37℃ in_vivo ∆gcvB+ksg | 754,811 | transcriptome-wide | |||
| Structure-seq (Nature, 2014) | DMS | A.thaliana | seeding in_vivo | 717,266 | transcriptome-wide |
| Structure-seq2 (NAR, 2017) | DMS | O.sativa | shoot_tissue in_vivo BiotinVAR custom_primer | 27,858 | transcriptome-wide |
| shoot_tissue in_vivo BiotinVAR standard_primer | 19,378 | transcriptome-wide | |||
| shoot_tissue custom_primer | 78,386 | transcriptome-wide | |||
| shoot_tissue standard_primer | 42,321 | transcriptome-wide | |||
| CIRS-seq (GenomeBiology, 2014) | DMS & CMCT | Mouse | mES in_vivo | 6,587,101 | transcriptome-wide |
| Mod-seq (RNA, 2014) | DMS | Yeast | rpl26Δ in_vivo | 1,222 | transcriptome-wide |
| BY4741 in_vivo | 1,258 | transcriptome-wide | |||
| DIM-2P-seq (Cell, 2017) | DMS | Human | HEK293T in_vivo | 1,777,482 | transcriptome-wide |
| DMS-MaPseq (Nature Methods, 2017) | DMS | Human | HEK293T in_vivo | 2,398,505 | transcriptome-wide |
| DMS | Yeast | BY4741 DMS in_vivo TGIRT | 5,407,062 | transcriptome-wide | |
| BY4741 DMS in_vivo SSii/Mn+ | 3,507,962 | transcriptome-wide | |||
| BY4741 2.5% DMS in_vivo | 1,169,814 | transcriptome-wide | |||
| BY4741 5% DMS in_vivo | 1,519,676 | transcriptome-wide | |||
| None | BY4741 TGIRT no-reagent | 1,491,993 | transcriptome-wide | ||
| BY4741 SSii/Mn+ no-reagent | 2,316,911 | transcriptome-wide | |||
| DMS-MaPseq (Nature, 2018) | DMS | Yeast | BY4741 Ded1p_Mutate in_vivo | 3,035,616 | transcriptome-wide |
| BY4741 WT in_vivo | 3,620,439 | transcriptome-wide | |||
| RAPiD-MaPseq (NAR, 2019) | DMS | IAV | A/Puerto Rico/8/1934(H1N1) in_vivo | 6,989 | transcriptome-wide |
| A/Puerto Rico/8/1934(H1N1) in_vitro | 6,991 | transcriptome-wide | |||
| SHAPE-MaP (Biochemistry, 2015) | 1M7 | Mouse | trophoblast stem cells incell | 30,944 | transcriptome-wide |
| trophoblast stem cells exvivo | 534 | transcriptome-wide | |||
| SHAPE-MaP (Cell, 2018) | 1M7 | E.coli | MG1655 cell_free | 368,290 | transcriptome-wide |
| MG1655 in_cell | 384,796 | transcriptome-wide | |||
| MG1655 Kasugamycin in_cell | 244,826 | transcriptome-wide | |||
| SHAPE-MaP (PNAS, 2015) | 1M7 | HCV | HCV in_vitro | 28,426 | transcriptome-wide |
| SHAPE (Nature, 2009) | 1M7 | HIV | HIV-1 in_vivo | 9,120 | transcriptome-wide |
| SHAPE-MaP (Nature Methods, 2014) | 1M6 | HIV | HIV-1 1M6 in_vivo | 9,159 | transcriptome-wide |
| 1M7 | HIV-1 1M7 in_vivo | 9,150 | transcriptome-wide | ||
| NMIA | HIV-1 NMIA in_vivo | 9,157 | transcriptome-wide | ||
| SHAPE-MaP (PLOS CompBio, 2015) | 1M7 | HIV | HIV in_vivo | 27,837 | transcriptome-wide |
| SHAPE-MaP (Mol. Cell, 2021) | NAI | SARS-CoV-2 | Wuhan-Hu-1 in_vivo | 29,848 | transcriptome-wide |
| SHAPE-MaP (PNAS, 2018) | 1M6 | Dengue | strain S16803 exviron_1M6 | 10,628 | transcriptome-wide |
| strain S16803 inviron_1M6 | 10,443 | transcriptome-wide | |||
| 1M7 | strain S16803 exviron_1M7 | 10,628 | transcriptome-wide | ||
| strain S16803 inviron_1M7 | 10,583 | transcriptome-wide | |||
| NMIA | strain S16803 exviron_NMIA | 10,633 | transcriptome-wide | ||
| strain S16803 inviron_NMIA | 10,637 | transcriptome-wide | |||
| NAI-MaP (Nature Communication, 2019) | NAI | Dengue | Dengue in_vivo | 42,545 | transcriptome-wide |
| NAI-MaP (Nature Communication, 2019) | NAI | Zika | ZIKV in_vivo | 42,932 | transcriptome-wide |
| SHAPE (Mol Cell, 2016) | NAI | HCV | JFH1 in_vitro | 8,815 | transcriptome-wide |
| SHAPE (BioChemistry, 2013) | 1M7 | STMV | STMV in_vitro | 946 | transcriptome-wide |
| STMV ex_vitro | 1,011 | transcriptome-wide | |||
| SHAPE-seq (NAR, 2018) | 1M7 | CMV | Bn57-CMV lyRNA in_plant_cell_lysates | 2,216 | transcriptome-wide |
| Bn57-CMV viRNA in_vitro | 2,216 | transcriptome-wide | |||
| icSHAPE (Cell Host & Microbe, 2018) | NAI-N3 | Zika | ZIKV in_vivo | 21,530 | transcriptome-wide |
| ZIKV in_vitro | 21,530 | transcriptome-wide | |||
| icSHAPE (Cell, 2021) | NAI-N3 | SARS-CoV-2 | Wuhan-Hu-1 in_vivo | 26,701 | transcriptome-wide |
| Wuhan-Hu-1 in_vitro | 27,649 | transcriptome-wide | |||
| icSHAPE (Nature, 2015) | NAI-N3 | Mouse | mES METTL3_KO in_vivo | 1,764,594 | transcriptome-wide |
| mES v65 in_vivo | 14,106,282 | transcriptome-wide | |||
| mES v65 in_vitro | 17,444,983 | transcriptome-wide | |||
| icSHAPE (Cell, 2016) | NAI-N3 | Human | HEK293T in_vivo | 2,030,707 | transcriptome-wide |
| HEK293T in_vitro | 1,854,626 | transcriptome-wide | |||
| icSHAPE (NSMB, 2019) | NAI-N3 | Mouse | mES chromatin in_vivo | 3,871,974 | transcriptome-wide |
| mES chromatin in_vitro | 2,969,374 | transcriptome-wide | |||
| mES cytoplasm in_vivo | 8,292,181 | transcriptome-wide | |||
| mES cytoplasm in_vitro | 6,340,837 | transcriptome-wide | |||
| mES nucleoplasm in_vivo | 9,899,971 | transcriptome-wide | |||
| mES nucleoplasm in_vitro | 10,473,036 | transcriptome-wide | |||
| NAI-N3 | Human | HEK293 chromatin in_vivo | 2,296,220 | transcriptome-wide | |
| HEK293 chromatin in_vitro | 3,701,135 | transcriptome-wide | |||
| HEK293 cytoplasm in_vivo | 2,146,114 | transcriptome-wide | |||
| HEK293 cytoplasm in_vitro | 6,895,344 | transcriptome-wide | |||
| HEK293 nucleoplasm in_vivo | 3,714,351 | transcriptome-wide | |||
| HEK293 nucleoplasm in_vitro | 8,169,250 | transcriptome-wide | |||
| icSHAPE (GenomeBiology, 2020) | NAI-N3 | Zebrafish | widetype AB strain fertilized_egg in_vivo | 7,294,463 | transcriptome-wide |
| widetype AB strain 1-cell in_vivo | 8,107,635 | transcriptome-wide | |||
| widetype AB strain 4-cell in_vivo | 8,024,909 | transcriptome-wide | |||
| widetype AB strain 64-cell in_vivo | 9,507,124 | transcriptome-wide | |||
| widetype AB strain shield in_vivo | 7,501,747 | transcriptome-wide | |||
| widetype AB strain sphere in_vivo | 12,022,502 | transcriptome-wide | |||
| widetype AB strain shield elavl1a-mo in_vivo | 5,675,258 | transcriptome-wide | |||
| widetype AB strain sphere elavl1a-mo in_vivo | 7,033,200 | transcriptome-wide | |||
| Keth-seq (NCB, 2020) | N3-kethoxal | Mouse | mES kethoxal vs kethoxal_removed in_vivo | 83,466 | transcriptome-wide |
| mES kethoxal_treated_1min vs no_treat in_vivo | 10,944 | transcriptome-wide | |||
| mES kethoxal_treated_5min vs no_treat in_vivo | 6,947 | transcriptome-wide | |||
| mES kethoxal vs no_treat in_vitro | 189,658 | transcriptome-wide | |||
| mES kethoxal vs no_treat in_vivo | 116,232 | transcriptome-wide | |||
| mES kethoxal vs no_treat | 60,593 | transcriptome-wide | |||
| N3-kethoxal | Human | HeLa kethoxal vs no treat in_vivo | 351,732 | transcriptome-wide | |
| HeLa kethoxal vs no treat in_vitro | 203,319 | transcriptome-wide | |||
| HeLa kethoxal vs no treat PDS in_vivo | 336,513 | transcriptome-wide | |||
| HeLa kethoxal vs no treat PDS in_vitro | 229,126 | transcriptome-wide | |||
| Lead-seq (NAR, 2020) | Lead(II) | Y.pseudotuberculosis | Lead-seq_25degree | 1,057,814 | transcriptome-wide |
| Lead-seq_37degree | 1,308,701 | transcriptome-wide | |||
| SHAPE-MaP (Biochemistry, 2019) | 1M6 | Dengue | strain S16803 exvirion_1M6 | 10,649 | transcriptome-wide |
| strain S16803 refolded_1M6 | 10,624 | transcriptome-wide | |||
| 1M7 | strain S16803 exvirion_1M7 | 10,647 | transcriptome-wide | ||
| strain S16803 refolded_1M7 | 10,624 | transcriptome-wide | |||
| NMIA | strain S16803 exvirion_NMIA | 10,650 | transcriptome-wide | ||
| strain S16803 exvirion_NMIA | 10,624 | transcriptome-wide | |||
| SHAPE-MaP (J. Virol, 2020) | 1M7 | CHIKV | CHIKV genome | 11,980 | transcriptome-wide |
| CHIKV 3'UTR dup | 798 | target-specific | |||
| CHIKV 3'UTR con | 633 | target-specific | |||
| CHIKV 3'UTR del | 520 | target-specific | |||
| SHAPE-MaP (J. Virol, 2022) | NAI | HCV | Jc1 invitro_full_genome | 9,432 | transcriptome-wide |
| pSGR-JFH1 invivo_subgenomic_replicon | 5,968 | target-specific | |||
| SHAPE-MaP & DMS-MaPseq (NAR, 2022) | 5NIA | Rotavirus | RF invitro_transcriptome_0uM_NSP2 | 17,910 | transcriptome-wide |
| RF invitro_transcriptome_5uM_NSP2 | 17,844 | transcriptome-wide | |||
| RF invitro_transcriptome_10uM_NSP2 | 17,798 | transcriptome-wide | |||
| RF invitro_transcriptome_20uM_NSP2 | 17,801 | transcriptome-wide | |||
| RF invitro_segment_5_6_10_11_0uM_NSP2 | 4,238 | transcriptome-wide | |||
| RF invitro_segment_5_6_10_11_5uM_NSP2 | 4,236 | transcriptome-wide | |||
| RF invitro_segment_5_6_10_11_10uM_NSP2 | 4,240 | transcriptome-wide | |||
| RF invitro_segment_5_6_10_11_20uM_NSP2 | 4,250 | transcriptome-wide | |||
| RF invivo_RFS11 | 597 | target-specific | |||
| DMS | RF RFS11_50mM_DMS | 598 | target-specific | ||
| RF RFS11_20uM_NSP2_50mM_DMS | 590 | target-specific | |||
| RF RFS11_10mM_DMS | 590 | target-specific | |||
| RF RFS11_20uM_NSP2_10mM_DMS | 590 | target-specific | |||
| SHAPE-MaP (Nat. Microbiol., 2019) | 1M7 | IAV | WSN/PR8/Udorn vRNP_invirio | 40,227 | transcriptome-wide |
| WSN in vitro transcribed RNA | 13,474 | transcriptome-wide | |||
| WSN naked viral RNA | 13,473 | transcriptome-wide | |||
| SHAPE-MaP & DMS-MaPseq (NAR, 2020) | NAI | SARS-CoV-2 | Leiden-0002 in vitro | 29,199 | transcriptome-wide |
| Leiden-0002 in vivo | 29,607 | transcriptome-wide | |||
| DMS | Leiden-0002 in vitro | 14,351 | transcriptome-wide | ||
| DMS-MaPseq (NC, 2022) | DMS | SARS-CoV-2 | USA-WA1 in vivo Huh7 | 10,228 | transcriptome-wide |
| USA-WA1 in vivo Vero | 14,413 | transcriptome-wide | |||
| SHAPE-MaP (NC, 2022) | NAI | SARS-CoV-2 | Wuhan-Hu-1 in vivo | 23,105 | transcriptome-wide |
| delta382 in vivo | 23,578 | transcriptome-wide | |||
| DMS-MaPseq (NM, 2021) | DMS | SARS-CoV-2 | Leiden-0002 in vitro | 14,413 | transcriptome-wide |
| SHAPE-MaP (Nature, 2021) | 1M7 | Human | human in vitro transcribed ABAT | 348 | target-specific |
| icSHAPE (Cell Res., 2021) | NAI-N3 | Human | HEK293 in vivo | 13,770,965 | transcriptome-wide |
| HeLa in vivo | 9,686,389 | transcriptome-wide | |||
| K562 in vivo | 12,566,202 | transcriptome-wide | |||
| HepG2 in vivo | 7,723,921 | transcriptome-wide | |||
| H9 in vivo | 11,994,944 | transcriptome-wide | |||
| Mouse | mES in vivo | 6,099,199 | transcriptome-wide | ||
| smartSHAPE (Fundamental Research, 2022) | NAI-N3 | Human | HEK293T in vivo 1ng | 9,509,617 | transcriptome-wide |
| HEK293T in vivo 5ng | 11,986,785 | transcriptome-wide | |||
| HEK293T in vivo 25ng | 11,120,239 | transcriptome-wide | |||
| HEK293T in vivo 125ng | 10,755,489 | transcriptome-wide | |||
| Mouse | C57BL/6J mouse Ly6Clo macrophages in vivo | 7,339,328 | transcriptome-wide | ||
| C57BL/6J mouse Ly6Chi macrophages in vivo | 4,997,290 | transcriptome-wide | |||
| SHAPE-MaP (Nature, 2023) | NAI | A.thaliana | seedling in planta elf | 6,864,135 | transcriptome-wide |
| seedling in planta mock | 6,749,684 | transcriptome-wide | |||
| icSHAPE & icLASER (NAR, 2021) | NAI-N3 | Human | K562 icSHAPE in vitro | 7,904,484 | transcriptome-wide |
| K562 icSHAPE in vivo | 9,538,140 | transcriptome-wide | |||
| Naz-N3 | K562 icLASER in vitro | 11,336,979 | transcriptome-wide | ||
| K562 icLASER in vivo | 10,769,117 | transcriptome-wide | |||
| icSHAPE (Cell, 2018) | NAI-N3 | Human | Coilin KO Hela in vitro hTR | 445 | target-specific |
| human in vitro transcribed hTR | 445 | target-specific | |||
| TCAB1 KO Hela in vitro hTR | 445 | target-specific | |||
| TCAB1 KO Hela in vitro rescue hTR | 445 | target-specific | |||
| TCAB1 KO Hela rescue hTR | 445 | target-specific | |||
| WT Hela in vitro hTR | 445 | target-specific | |||
| icSHAPE-MaP (NC, 2021) | NAI-N3 | Human | HEK293T in vivo sRNA | 25,320 | transcriptome-wide |
| HEK293T in vitro sRNA | 32,050 | transcriptome-wide | |||
| HEK293T Dicer-enriched RNA | 71,468 | transcriptome-wide | |||
| SHAPE-MaP (PNAS, 2016) | 1M6 | Mouse | TSC ex vivo 1M6 Xist | 15,356 | target-specific |
| NMIA | TSC ex vivo NMIA Xist | 15,368 | target-specific | ||
| 1M7 | TSC ex vivo 1M7 Xist | 15,412 | target-specific | ||
| TSC in cell 1M7 Xist | 15,412 | target-specific | |||
| SHAPE-MaP (RNA, 2023) | 5NIA | Human | A549 in vivo MALAT1 | 6,674 | target-specific |
| HEK293 in vivo MALAT1 | 6,583 | target-specific | |||
| Human ex vivo MALAT1 | 6,630 | target-specific | |||
| Green monkey | Vero in vivo MALAT1 | 6,712 | target-specific | ||
| Vero ex vivo MALAT1 | 6,705 | target-specific | |||
| DMS-MaPseq (RNA, 2021) | DMS | B.subtilis | BS168 in vivo ctc isoform | 228 | target-specific |
| BS168 in vivo yvrE isoform | 206 | target-specific | |||
| SHAPE-seq & Cotranscriptional SHAPE-seq (NAR, 2022) | BzCN | B.subtilis | B. subtilis in vitro transcribed equilibrium 135nt yxjA | 135 | target-specific |
| B. subtilis in vitro transcribed equilibrium 160nt yxjA | 160 | target-specific | |||
| B. subtilis in vitro transcribed equilibrium 220nt yxjA | 220 | target-specific | |||
| B. subtilis in vitro transcribed cotranscriptional 135nt yxjA | 135 | target-specific | |||
| B. subtilis in vitro transcribed cotranscriptional 160nt yxjA | 160 | target-specific | |||
| B. subtilis in vitro transcribed cotranscriptional 220nt yxjA | 220 | target-specific | |||
| SHAPE-MaP (NAR, 2021) | 1M4 | E.coli | DH10B in vivo 1M4 16S & 23S | 4,296 | target-specific |
| DH10B ex vivo 1M4 16S & 23S | 4,356 | target-specific | |||
| 2A3 | DH10B in vivo 2A3 16S & 23S | 4,269 | target-specific | ||
| DH10B ex vivo 2A3 16S & 23S | 4,277 | target-specific | |||
| 6A3 | DH10B in vivo 6A3 16S & 23S | 4,385 | target-specific | ||
| DH10B ex vivo 6A3 16S & 23S | 4,352 | target-specific | |||
| B5 | DH10B in vivo B5 16S & 23S | 4,267 | target-specific | ||
| DH10B ex vivo B5 16S & 23S | 4,335 | target-specific | |||
| I5 | DH10B in vivo I5 16S & 23S | 4,297 | target-specific | ||
| DH10B ex vivo I5 16S & 23S | 4,354 | target-specific | |||
| NAI | DH10B in vivo NAI 16S & 23S | 4,291 | target-specific | ||
| DH10B ex vivo NAI 16S & 23S | 4,359 | target-specific | |||
| NIC | DH10B in vivo NIC 16S & 23S | 4,270 | target-specific | ||
| DH10B ex vivo NIC 16S & 23S | 4,357 | target-specific | |||
| 1M4 | B.subtilis | BS168 in vivo 1M4 16S & 23S | 4,370 | target-specific | |
| 2A3 | BS168 in vivo 2A3 16S & 23S | 4,360 | target-specific | ||
| 6A3 | BS168 in vivo 6A3 16S & 23S | 4,366 | target-specific | ||
| B5 | BS168 in vivo B5 16S & 23S | 4,370 | target-specific | ||
| I5 | BS168 in vivo I5 16S & 23S | 4,370 | target-specific | ||
| NAI | BS168 in vivo NAI 16S & 23S | 4,363 | target-specific | ||
| NIC | BS168 in vivo NIC 16S & 23S | 4,361 | target-specific | ||
| 1M4 | Human | HEK293 in vivo 1M4 18S & 28S | 6,586 | target-specific | |
| 2A3 | HEK293 in vivo 2A3 18S & 28S | 6,504 | target-specific | ||
| 6A3 | HEK293 in vivo 6A3 18S & 28S | 6,752 | target-specific | ||
| B5 | HEK293 in vivo B5 18S & 28S | 6,404 | target-specific | ||
| I5 | HEK293 in vivo I5 18S & 28S | 6,554 | target-specific | ||
| NAI | HEK293 in vivo NAI 18S & 28S | 6,590 | target-specific | ||
| NIC | HEK293 in vivo NIC 18S & 28S | 6,597 | target-specific | ||
| Structure-Seq (PLoS Genet., 2015) | DMS | Mouse | MEF higher DMS Xist | 8,262 | target-specific |
| MEF lower DMS Xist | 8,425 | target-specific | |||
| Structure-Seq (Genetics, 2019) | DMS | Yeast | BY4741 in vivo | 7,573,162 | transcriptome-wide |
| dbp2delta in vivo | 7,876,634 | transcriptome-wide | |||
| tNet-MaPseq & tNet-RNase-seq (Mol. Cell, 2021) | DMS | Human | HEK293 tNet-MaP_WT nascent RNA | 119,951,120 | transcriptome-wide |
| HEK293 tNet-MaP_R749H nascent RNA | 54,430,713 | transcriptome-wide | |||
| RNase | HEK293 tNet-Rnase-seq WT without protein footprints | 60,728,379 | transcriptome-wide | ||
| HEK293 tNet-Rnase-seq WT including repetitive elements | 77,649,478 | transcriptome-wide | |||
| HEK293 tNet-Rnase-seq R749H without protein footprints | 45,637,400 | transcriptome-wide | |||
| HEK293 tNet-Rnase-seq R749H including repetitive elements | 52,697,302 | transcriptome-wide | |||
| DMS-MaPseq (Front. Plant Sci., 2022) | None | O.sativa | seedling noDMS 18S rRNA | 353 | target-specific |
| seedling noDMS 5'UTR PHO2 | 370 | target-specific | |||
| seedling root noDMS 18S rRNA | 353 | target-specific | |||
| seedling noDMS genome | 65,406 | transcriptome-wide | |||
| DMS | seedling shaking 1% DMS 18S rRNA | 353 | target-specific | ||
| seedling shaking 2% DMS 18S rRNA | 353 | target-specific | |||
| seedling shaking 2.5% DMS 18S rRNA | 353 | target-specific | |||
| seedling vacuum 1% DMS 18S rRNA | 353 | target-specific | |||
| seedling vacuum 2% DMS 18S rRNA | 353 | target-specific | |||
| seedling vacuum 2.5% DMS 18S rRNA | 353 | target-specific | |||
| seedling 5'UTR PHO2 | 370 | target-specific | |||
| seedling root 1% DMS 18S rRNA | 353 | target-specific | |||
| seedling genome | 74,332 | transcriptome-wide | |||
| Nuc-SHAPE-Structure-Seq (Genome Biol., 2021) | NAI | A.thaliana | seedling in vivo | 5,411,900 | transcriptome-wide |
| seedling deproteinized | 7,322,805 | transcriptome-wide | |||
| DMS-MaPseq (PNAS, 2021) | DMS | Yeast | BY4741 purified mature 40S | 1,800 | target-specific |
| BY4741 WT purified pre-40S | 1,800 | target-specific | |||
| BY4741 Rio2_dloop mutant purified pre-40S | 1,800 | target-specific | |||
| BY4741 S15_YRR mutant purified pre-40S | 1,800 | target-specific | |||
| ChemModSeq (NAR, 2014) | 1M7 | Yeast | BY4741 purified 20S Enp1 | 1,800 | target-specific |
| BY4741 purified 20S Ltv1 | 1,800 | target-specific | |||
| BY4741 purified 20S Rio2 | 1,800 | target-specific | |||
| BY4741 purified 20S Tsr1 | 1,800 | target-specific | |||
| BY4741 purified 20S Nob1 | 1,800 | target-specific | |||
| BY4741 purified 20S Rio1 | 1,800 | target-specific | |||
| BY4741 purified 20S 80S like | 1,800 | target-specific | |||
| BY4741 purified 18S 80S | 1,800 | target-specific | |||
| DMS | BY4741 purified 18S | 1,800 | target-specific | ||
| NAI | BY4741 purified 20S Tsr1 | 1,800 | target-specific | ||
| BY4741 purified 20S Rio1 | 1,800 | target-specific | |||
| BY4741 purified 18S 80S | 1,800 | target-specific | |||
| None | BY4741 purified 20S midearly control | 1,800 | target-specific | ||
| BY4741 purified 18S late control | 1,800 | target-specific | |||
| BY4741 purified 18S DMS control | 1,800 | target-specific | |||
| BY4741 purified 20S Tsr1 DMSO | 1,800 | target-specific | |||
| BY4741 purified 18S 80S DMSO | 1,800 | target-specific | |||
| Mod-seq (NAR, 2018) | 1M7 | Mouse | mouse NEAT1_S | 3,176 | target-specific |
| Human | human NEAT1_S | 3,595 | target-specific | ||
| SHAPE-seq (Biochemistry, 2017) | 1M7 | S.enterica | ecoli TG1 30°C A29C mutant agsA 5'UTR | 61 | target-specific |
| ecoli TG1 30°C G21C mutant agsA 5'UTR | 61 | target-specific | |||
| ecoli TG1 30°C WT agsA 5'UTR | 61 | target-specific | |||
| ecoli TG1 42°C A29C mutant agsA 5'UTR | 61 | target-specific | |||
| ecoli TG1 42°C G21C mutant agsA 5'UTR | 61 | target-specific | |||
| ecoli TG1 42°C WT agsA 5'UTR | 61 | target-specific | |||
| in vitro folding 30°C A29C mutant agsA 5'UTR | 61 | target-specific | |||
| in vitro folding 30°C G21 mutant agsA 5'UTR | 61 | target-specific | |||
| in vitro folding 30°C WT agsA 5'UTR | 61 | target-specific | |||
| in vitro folding 42°C A29C mutant agsA 5'UTR | 61 | target-specific | |||
| in vitro folding 42°C G21 mutant agsA 5'UTR | 61 | target-specific | |||
| in vitro folding 42°C WT agsA 5'UTR | 61 | target-specific | |||
| in vitro folding 30°C modified protocol agsA 5'UTR | 61 | target-specific | |||
| in vitro folding 80°C modified protocol agsA 5'UTR | 61 | target-specific | |||
| in vitro PURExpress active trans 30°C | 61 | target-specific | |||
| in vitro PURExpress active trans 42°C | 61 | target-specific | |||
| in vitro PURExpress no ribosome trans 30°C | 61 | target-specific | |||
| in vitro PURExpress no ribosome trans 42°C | 61 | target-specific | |||
| in vitro PURExpress trans init stalled 30°C | 61 | target-specific | |||
| in vitro PURExpress trans init stalled 42°C | 61 | target-specific | |||
| Cotranscriptional SHAPE-seq (Mol. Cell, 2021) | BzCN | E.coli | ecoli U21C_C22U_G93A cotranscriptional SHAPE-seq SRP | 114 | target-specific |
| ecoli U21C cotranscriptional SHAPE-seq SRP | 114 | target-specific | |||
| ecoli U21C equilibrium-refolded SHAPE-seq SRP | 114 | target-specific | |||
| Cotranscriptional SHAPE-seq (Nat. Struct., 2016) | BzCN | B.cereus | B.cereus WT 0mM NaF crcB | 82 | target-specific |
| B.cereus WT 10mM NaF crcB | 82 | target-specific | |||
| B.cereus WT refold 10mM NaF crcB | 82 | target-specific | |||
| B.cereus M18 0mM NaF crcB | 82 | target-specific | |||
| B.cereus M18 10mM NaF crcB | 82 | target-specific | |||
| B.cereus M19 0mM NaF crcB | 82 | target-specific | |||
| B.cereus M19 10mM NaF crcB | 82 | target-specific | |||
| B.cereus M20 0mM NaF crcB | 82 | target-specific | |||
| B.cereus M20 10mM NaF crcB | 82 | target-specific | |||
| B.cereus M21 0mM NaF crcB | 82 | target-specific | |||
| B.cereus M21 10mM NaF crcB | 82 | target-specific | |||
| B.cereus M22 0mM NaF crcB | 82 | target-specific | |||
| B.cereus M22 10mM NaF crcB | 82 | target-specific | |||
| B.cereus M23 0mM NaF crcB | 82 | target-specific | |||
| B.cereus M23 10mM NaF crcB | 82 | target-specific | |||
| E.coli | E.coli BzCN SRP | 114 | target-specific | ||
| E.coli BzCN refold SRP | 114 | target-specific | |||
| DMS | E.coli DMS SRP | 114 | target-specific | ||
| icSHAPE (Cell Rep., 2024) | NAI-N3 | IAV | WSN in vivo | 13,301 | transcriptome-wide |
| WSN in virio | 13,301 | transcriptome-wide | |||
| RL-seq (RNA Biol., 2022) | hydroxyl radical | E.coli | E.coli 16S UMI in vitro | 1,521 | target-specific |
| E.coli 23S UMI in vitro | 2,892 | target-specific | |||
| E.coli 5S UMI in vitro | 105 | target-specific |